Investors Overview

Webcast ImageWebcast
Q1 2015 Bacterin International Holdings Inc Earnings Conference Call (Live)
05/06/15 at 10:00 a.m. ET
Q1 2015 Bacterin International Holdings Inc Earnings Conference Call
Wednesday, May 6, 2015 10:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile

Bacterin International Holdings, Inc., Belgrade, MT (OTCQX: BONE), a developer of bioactive coatings for medical applications and revolutionary bone graft material, processes and markets innovative, biologic allografts for transplantation. The Company’s biologic scaffolds, OsteoSponge®, OsteoSponge® SC and OsteoWrap®, are made from demineralized bone that is malleable and flexible, which enables more efficient and precise handling. It also markets BacFast® and OsteoLock®, which are used in...
More

Stock Quote
BONE (Common Stock)
ExchangeOTC BB (US Dollar)
Price$4.25
Change (%) Stock is Up 0.05 (1.19%)
Volume1,900
Data as of 05/01/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Stock Chart
Stock chart for: 03NA000000BONE
Recent News
DateTitle 
04/28/15Bacterin International Receives Coverage From Medicare Administrative Contractor (MAC) for hMatrix(R)
BELGRADE, Mont., April 28, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary allograft, today announced that its Acellular Dermal Matrix allograft (ADM), hMatrix®, has received coverage from Novitas Solutions, Inc. ("Novitas"), a Medicare Administrative Contractor, or "MAC". Novitas is one of eight MACs that are responsible for processing Medicare claims in one or more of twelve geographic areas, or "jurisdictions," in t... 
Printer Friendly Version
04/23/15Bacterin to Report First Quarter 2015 Financial Results on May 5, 2015
BELGRADE, Mont., April 23, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary bone graft material, today announced that it will release its financial results for the period ended March 31, 2015, on May 5, 2015 at the close of the financial markets. An accompanying conference call will be hosted by Dan Goldberger, Chief Executive Officer, and John Gandolfo, Chief Financial Officer, to discuss the results. The call will be ... 
Printer Friendly Version
04/09/15Bacterin Announces Preliminary First Quarter 2015 Results
First Quarter Total Revenue Expected to be in the Range of $9.4 Million to $9.5 Million, an Increase of Approximately 5-7% Over the Same Period Last Year BELGRADE, Mont., April 9, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (OTCQX:BONE), a leader in the development of revolutionary bone graft material, today announced preliminary unaudited results for the first quarter of 2015. The Company is anticipating total net revenue for the first quarter of 2015 to be in the range ... 
Printer Friendly Version
04/08/15Bacterin International to Begin Trading on OTCQX Marketplace
BELGRADE, Mont., April 8, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material, today announced that it received written notice from the staff at NYSE Regulation, Inc. that trading in the company's common stock will be suspended on the NYSE MKT, and the company's common stock will begin trading on the OTCQX(R) marketplace. The suspension notice follows the company's previously announced appeal of NYSE Reg... 
Printer Friendly Version
More

Upcoming Events
DateTitle
05/06/15 10:00 a.m. ET
Q1 2015 Bacterin International Holdings Inc Earnings Conference Call
More

Receive E-mail Alerts
Sign up to receive e-mail alerts whenever Bacterin International Holdings Inc posts new information to the site. Just enter your e-mail address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.